Forte Biosciences (FBRX) Misses Q3 EPS by 433c
Tweet
Share
E-mailGet Alerts FBRX Hot Sheet
Join SI Premium – FREE
Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($4.54), $4.33 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- Rothschild Redburn Upgrades Equifax (EFX) to Buy
- Goldman Sachs Downgrades Shanghai Jahwa United (600315:CH) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
